Conquering Diseases

Study Of An Experimental Drug For Melanoma Skin Cancer

Description

Seeking men and women who have been diagnosed with melanoma skin cancer and will have surgery to remove it for a study of whether starting the experimental drug before surgery is better or worse than starting the drug after surgery.

Overview

Participants in this trial will either start receiving the experimental drug before surgery to treat their melanoma skin cancer or after surgery so that we can evaluate which is best.

What we're hoping for

Evaluate whether starting the experimental drug before surgery to treat melanoma skin cancer is better or worse than starting the drug after surgery.

Additional Information

ClinicalTrials.gov Identifier: NCT03698019

 Principal Investigator

Tasneem  Ali, MD

UMass Memorial Health Care

 Study Contact

The Cancer  Research Office

508-856-3216

Cancer.research@umassmed.edu

 Location

UMMS University Campus

55 Lake Ave North 

Worcester,MA 01655

508-856-8989